Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats

Despite the crucial role of Polymyxin-B in treating life-threatening gram-negative infections, its clinical utility is limited due to the risk of acute kidney injury. In response, a novel formulation of polymyxin-B is being developed to mitigate drug-induced kidney injury. In this study, we have ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Dilip, Kulkarni, Amol, Chaudhary, Manu, Chaudhary, Saransh, Payasi, Anurag, Aggarwal, Anmol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065941/
https://www.ncbi.nlm.nih.gov/pubmed/33800696
http://dx.doi.org/10.3390/antibiotics10040359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065941/
https://www.ncbi.nlm.nih.gov/pubmed/33800696
http://dx.doi.org/10.3390/antibiotics10040359

Ejemplares similares